Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Oncology|October 29, 2018
Impact of Epidermal Growth Factor Receptor Mutation on Clinical Outcomes of Nintedanib Plus Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer from the Korean Named Patient ProgramSook-Hee Hong, Ho Jung An, Kihyun Kim, et al.
Thoracic Cancer|November 11, 2019
Geriatric Nutritional Risk Index as a prognostic marker in patients with extensive-stage disease small cell lung cancer: Results from a randomized controlled trialGyeong-Won Lee, Se-Il Go, Dong-Wan Kim, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 27, 2022
Discussing POLST-facilitated hospice care enrollment in patients with terminal cancerHo Jung An, Hyun Jeong Jeon, Sang Hoon Chun, et al.
Journal of Gastroenterology and Hepatology|November 25, 2010
Sustained low hepatitis B viral load predicts good outcome after curative resection in patients with hepatocellular carcinomaHo Jung An, Jeong Won Jang, Si Hyun Bae, et al.
Journal of Korean Medical Science|February 6, 2015
Experience of advance directives in a hospice centerBong Han Kong, Ho Jung An, Hyun Seon Kim, et al.
Annals of Surgical Oncology|September 21, 2013
The effects of surgical cytoreduction prior to imatinib therapy on the prognosis of patients with advanced GISTHo Jung An, Min-Hee Ryu, Baek-Yeol Ryoo, et al.
Cancer Research and Treatment|April 20, 2019
Feasibility Study of Physician Orders for Life-Sustaining Treatment for Patients with Terminal CancerHo Jung An, Hyun Jeong Jeon, Sang Hoon Chun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2022
A Phase II Study of Nivolumab plus Gemcitabine in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma (KCSG HN17-11)Hyun Ae Jung, Keon-Uk Park, Sanghee Cho, et al.
Pathology, Research and Practice|June 25, 2017
Prognostic implication of ERCC1 protein expression in resected oropharynx and oral cavity cancerHo Jung An, Heejoon Jo, Chan Kwon Jung, et al.
Cancer Research and Treatment|July 21, 2023
A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH TrialKyoo Hyun Kim, Sun Min Lim, Hee Kyung Ahn, et al.
Pageof 8